Cancer Care

 

 
A Multi-Site Retrospective Observational Study Of Us Patients With Unresectable Or Metastatic Melanoma Receiving Ipilimumab (Yervoy®) As First-Line Therapy
Principal Investigator (?)
Study Number
F13048
Phase (?)
N/A
Sponsor (?)
Available at the following location(s)

Lebanon

Contact Information

For more information about a clinical trial, clinical trial eligibility, or informed consent, contact our research nurses by phone or email:

Please Note: Any eligibility criteria noted are subject to change. Our research nurses can provide you with the most current eligibility and exclusion criteria. Any study involvement to be undertaken must ultimately be determined on an individual basis.